ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

18.35
Delayed Data
As of Mar 23
 -0.15 / -0.81%
Today’s Change
12.24
Today|||52-Week Range
28.06
+15.26%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Brege Laura A
Director
Sale1/12/202312,500$18.25$228.1K-0.11%
Brege Laura A
Director
Buy1/12/202312,500$17.01$212.6K-0.11%
Davis Stephen R
Chief Executive Officer
Sale5/02/20225,483$18.18$99.7K-6.24%
Baker Bros Advisors Lp
Director
Buy1/12/202315,000$5.22$78.3K-0.11%
Baker Bros Advisors Lp
Director
Buy1/12/202315,000$5.22$78.3K-0.11%
Davis Stephen R
Chief Executive Officer
Sale2/24/20233,851$18.78$72.3K-3.17%
Davis Stephen R
Chief Executive Officer
Sale1/09/20233,904$17.13$66.9K+8.66%
Stankovic Srdjan R
President
Sale5/02/20222,865$18.18$52.1K-6.24%
Davis Stephen R
Chief Executive Officer
Sale10/15/20222,804$15.81$44.3K+14.79%
Stankovic Srdjan R
President
Sale11/21/20221,847$15.07$27.8K+23.95%
Page of 4